Systematic review / meta-analysis / 2012
Alzheimer's disease was linked to higher copper levels in a meta-analysis.
Researchers updated a meta-analysis on copper levels in serum, plasma, and cerebrospinal fluid in Alzheimer's disease. The authors excluded four of five previous studies from their laboratory to limit bias and added two newer serum copper investigations. Across the analyzed studies, patients with Alzheimer's disease demonstrated higher copper concentrations than healthy controls.
- Study type
- Meta-analysis
- Who was studied
- Patients with Alzheimer's disease and controls across published studies
- What was measured
- Copper concentrations in serum, plasma, and cerebrospinal fluid
THE PAPER
Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies.
Ventriglia M, Bucossi S, Panetta V, Squitti R. J Alzheimers Dis, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.